(IN BRIEF) An international team of researchers, including Empa scientists, is developing nanozymes to treat inflammation during pregnancy without harming the mother or fetus. These tiny particles, which have enzyme-like properties, could provide a safer alternative to traditional medications. Initial … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Security & Safety, Switzerland, Technology
Tagged anti-inflammatory, antibacterial, biotechnology, Empa, Empa research, fetal health, Healthcare Innovation, human placental tissue, inflammation, maternal health, nanomedicines, nanotechnology, nanozymes, Nikolaos Tagaras, placenta chip, placental barrier, pregnancy complications, pregnancy research, prenatal care, safe treatment, Swiss National Science Foundation, Tina Bürki
(IN BRIEF) NIB has financed the Gene Therapy Centre in Lithuania, a groundbreaking facility advancing gene therapy research and manufacturing. Opened in September, it is a critical part of Lithuania’s life sciences sector, contributing to the country’s goal of growing … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Finland, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Lithuania, Management, News, Pharma & Biotech, Science, Technology
Tagged BIO CITY, biotechnology, Celltechna, economic growth, gene therapy, Gene Therapy Centre, investments, life sciences, Lithuania, NIB, Nordic-Baltic region, partnership, research and manufacturing, strategic partnerships, sustainability
(IN BRIEF) WACKER and BENEO have launched 2’-Fucosyllactose (2’-FL), a human milk oligosaccharide (HMO), for early-life nutrition. Available initially in Europe, this product is part of a strategic partnership aimed at enhancing the availability of HMOs in the market. The … Read the full press release
Posted in Business, Chemicals, Environment, Financial, Food & Beverage, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged 2’-fucosyllactose, BENEO, biotechnology, Early Life Nutrition, gut microbiota, HMO, Human Milk Oligosaccharides, immune system, infant formula, Market Growth, partnership, prebiotics, Precision Fermentation, strategic partnership, sustainability, WACKER
(IN BRIEF) Researchers from the University of Copenhagen have made a breakthrough in the biosynthetic production of Taxol, a widely used chemotherapy drug. By identifying the enzymes responsible for the final steps in the biosynthetic pathway of Taxol, the team … Read the full press release
Posted in Business, Denmark, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged biosynthetic production, biotechnology, cancer treatment, chemotherapy, environmental sustainability, Feiyan Liang, ovarian cancer, Pacific yew tree, pharmaceutical innovation, Sotirios Kampranis, sustainable drug production, sustainable medicine, Taxol, University of Copenhagen
(IN BRIEF) Fraunhofer institutes have launched the BIOSYNTH project, developing a high-throughput microchip platform that uses synthetic DNA to address the growing data storage crisis. This innovative solution promises a space-saving, low-cost, and energy-efficient alternative for mass data storage, with … Read the full press release
Posted in Business, Environment, Financial, Germany, Industrial, Investment, Management, News, Science, Technology
Tagged big data technologies, Bioinformatics, BIOSYNTH project, biotechnology, data storage solutions, Fraunhofer, Hybrotec GmbH, Infineon Technologies, mass data storage, microchip platform, personalized medicine, substance screening, sustainability, synthetic biology, synthetic DNA, X-FAB Semiconductor Foundries
(IN BRIEF) Empa researchers have developed a printable, non-swelling hydrogel made from cold-water fish gelatin, enabling the creation of 3D living skin models. Designed to replicate the full complexity of human skin, including its layered architecture and cellular composition, the … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Switzerland, Technology
Tagged 3D bioprinting, artificial skin, biointerfaces, biologically compatible materials, biomimetic membranes, biotechnology, cod gelatin, cold-water fish gelatin, customized wound dressing, electrospinning, Empa, Empa Biomimetic Membranes and Textiles, Empa Laboratory for Biointerfaces, extracellular matrix, gelatin-based material, hydrogel, immune response, Kongchang Wei, Medical Innovation, non-swelling hydrogel, personalized medicine, printable hydrogel, Regenerative medicine, skin disease research, SKINTEGRITY.CH, Swiss research, synthetic skin models, Tissue Engineering, University Medicine Zurich, wound healing
(IN BRIEF) Evonik will present its expanded portfolio at PCHi 2025 in Guangzhou, showcasing advanced biotechnology and products tailored to the regional market across various sectors. The company’s Care Solutions business focuses on meeting the growing demand for eco-friendly and … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Chemicals, Environment, Financial, Germany, Government, Industrial, Investment, Management, Media, News, Science, Technology
Tagged active ingredients, air care, Alix Chen, Biosurfactants, biotechnology, care solutions, ceramide innovation, Cleansing, dermosoft® EcoLact C MB, eco-friendly products, Evonik, Golden C® NG, Guangzhou, hair care, HAIRMIMICS® Boost, household cleaning, makeup removers, PCHi 2025, personal care, Product Protection, regional market, REWOFERM® series, RHEANCE® One, skin care, SOPHANCE® LA-A, SPHINGONY® sphingolipid, sun care, sustainability, symbio®pure G3C2 MB, system solutions
(IN BRIEF) Evonik has developed a groundbreaking model of the skin microbiome that allows for realistic, scientifically validated testing of how cosmetic ingredients impact the skin’s microbial communities. This model recreates the complex interactions between microbes, providing more accurate insights … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Chemicals, Environment, Financial, Germany, Industrial, Investment, Management, News, Science, Technology
Tagged biotechnology, Cosmetics Testing, Evonik, Skin Microbiome Model, sustainability
(IN BRIEF) Kembara Fund I FCR, a €1 billion deep tech and climate-focused fund managed by Spain-based Alma Mundi Ventures, has secured a €350 million commitment from the European Investment Fund (EIF). As the first Spanish fund to be selected … Read the full press release
Posted in European Union, Financial, Investment, Luxembourg, Small Business, Spain, Technology, Telecom
Tagged AI, Alma Mundi Ventures, artificial intelligence, Atomico Growth VI, biotechnology, Capital Markets Union, capital-intensive businesses, cleantech, Climate Innovation, competitiveness, Cybersecurity, deep tech, digital technologies, digital transformation, EIF, engineering breakthroughs, ETCI, Europe, European Investment Fund, European Tech Champion Initiative, European tech champions, Factorial, financial technologies, France, frontier technologies, FSI II, Germany, growth-stage startups, Healthcare, Inke, intellectual property, Javier Santiso, Keensight Nova VI, Kembara Fund I FCR, life sciences, Marjut Falkstedt, Mundi Ventures, next-generation energy systems, public and private resources, quantum technologies, robotics, scientific breakthroughs, Space tech, Spain, Startups, strategic autonomy, Sweden, tech ecosystem, transformative ventures
(IN BRIEF) Covestro has inaugurated a groundbreaking pilot plant at its Leverkusen site, heralding a significant leap in chemical production. This innovative facility is set to produce aniline—a crucial chemical component—solely from plant biomass, departing from traditional petroleum-based methods. Aniline … Read the full press release
(IN BRIEF) Evonik has successfully completed its industrial-scale facility for sustainable biosurfactants in Slovakia, becoming the world’s first plant to produce sustainable rhamnolipid biosurfactants. These high-quality biosurfactants are manufactured through a biogenic, carbon-based fermentation process, eliminating the need for petrochemical … Read the full press release
Posted in Business, Chemicals, Construction, Education, Environment, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Management, News, Science, Slovakia, Technology
Tagged biotechnology, Evonik, facility, Johann-Caspar Gammelin, partnership, rhamnolipid biosurfactants, Slovakia, sustainability, Yann d'Hervé
(IN BRIEF) The BioSense Institute in Novi Sad has opened a new building offering modern facilities for scientific research and business ventures in the fields of agriculture and biotechnology. The €34 million project was financed by €14 million in EU … Read the full press release
Posted in Agriculture, Banks, Education, European Union, Financial, Investment, Pharma & Biotech, Science, Serbia, Small Business, Technology
Tagged agriculture, Ana Brnabić, ANTARES project, BioSense Institute, biotechnology, Branko Ružić, EIB, European Investment Bank, Felicitas Riedl, Igor Mirović, Jelena Begović, Jelena Tanasković, life sciences, Mariya Gabriel, Marko Blagojević, Mihailo Jovanović, Novi Sad, scientific research, SERBIA, Startups, Tanja Miščević, University of Novi Sad, Vladimir Crnojević, Youth Mariya Gabriel
(IN BRIEF) The Conference Forum has announced that the 7th annual European Patients as Partners® in Clinical Research conference will take place in London on June 12-13, 2023. The event will focus on achieving greater representation in clinical research, building … Read the full press release
Posted in Government, Healthcare, News, Non Profit, Pharma & Biotech, United Kingdom
Tagged 7th annual European Patients as Partners®, biotechnology, Boehringer Ingelheim, Center for BME Health, clinical development, clinical research, Clinical Research conference, clinical trials, Community Engagement, CSL Behring, Deirdre BeVard, Diversity in Clinical Research, drug development, government, Health Equity, Healthcare, Hospital, Lundbeck, Medicine Development, Medicine Lifestyle, Medicines Development, Novartis, Patient Advocacy, Patient Centricity, Patient Communities, patient engagement, Patient Perspective, Patient Recruitment, Patient Retention, Patient Voice, Patients as Partners, Pharmaceutical, research and development, Sanofi, The Conference Forum, Thistle Hotel Marble Arch, Valerie Bowling
(IN BRIEF) Bayer has announced the recipients of its 2023 Grants4Ag program, which will provide funding and mentorship to researchers working on sustainability and biotechnology in agriculture. The program will award grants ranging from €5,000 to €15,000 and connect researchers … Read the full press release
Posted in Agriculture, Awards, Business, Germany, Management, News, Pharma & Biotech, Science, Technology
Tagged agriculture, Awards, Bayer, biotechnology, Dr. Phil Taylor, grants, Grants4Ag program, innovative, mentorship, Prof. Ji Zhou, researchers, sustainability
(IN BRIEF) Researchers from the Ecole Normale Supérieure in Lyon and the University of Freiburg’s Institute of Physiology have cast doubt on the accepted model of creating electropores in biomembranes using electric fields. Electroporation is used to create targeted defects … Read the full press release
(IN BRIEF) UK Research and Innovation has launched the Biotech Business Incubation Centre (Bio BIC) in the north-west of England to support small biotech businesses. Bio BIC, a collaboration between the Biotechnology and Biological Sciences Research Council and the Science … Read the full press release
Posted in Financial, News, Science, Technology, United Kingdom
Tagged Amy Farrington, BBSRC, Bio BIC, bioscience, Biotech Business Incubation Centre, biotechnology, Dr Karen Lewis, funding, Massimo Noro, Paul Vernon, R&D, Sci-Tech Daresbury, start-ups, Steve Rotheram, STFC, UK Research and Innovation, UKRI
Tony Wood to assume full accountability for GSK R&D in August 2022 Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to support R&D (PRESS RELEASE) LONDON, 19-Jan-2022 — /EuropaWire/ — GlaxoSmithKline … Read the full press release
Posted in Artificial Intelligence (AI), Healthcare, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Academy of Medical Sciences, Adrestia, Altius Institute, Altos Labs, appointment, artificial-intelligence, biotechnology, Blenrep, Board of the Rosalind Franklin Institute, Cabenuva, Chief Scientific Officer, CSO, Dr. Hal Barron, Emma Walmsley, Genome Research, genomics, GlaxoSmithKline plc, GSK, immunology, Imperial College, infectious disease, Jemperli, Machine Learning, medicines, Nucala®, oncology, Pfizer, R&D, research and development, Royal Society of Biology, Royal Society of Chemistry, Tony Wood, UK National Genomics Board, University of Newcastle, Xevudy
Origimm brings expertise in antigen discovery for immune modulation of skin microbiome-associated disorders Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide Sanofi to leverage its next-generation mRNA platform to unlock … Read the full press release
Posted in Austria, Business, France, Healthcare, News, Pharma & Biotech
Tagged acne, acne vulgaris, acquisition, antigens, biotechnology, Cutibacterium acnes bacterium, microbiome, mRNA, ORI-001, Origimm Biotechnology GmbH, Sanofi, Sanya Selak, skin disease, skin immunology, skin microbiome, Thomas Triomphe, virulent skin microbiome
New arrangement leverages Kuehne+Nagel’s global solutions for pharma & healthcare logistics (PRESS RELEASE) CAMBRIDGE, MA, U.S.A. / SCHINDELLEGI, 7-Jan-2021 — /EuropaWire/ — Global transport and logistics company Kuehne+Nagel announces international supply chain arrangement with Moderna, Inc. (NASDAQ:MRNA), a biotechnology company … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Switzerland, Technology, Transportation & Logistics
Tagged biotechnology, Covid-19 Vaccine Moderna, Dan Staner, distribution, Dominique Nadelhofer, EMA, European Medicines Agency, Harriet Barham, Kuehne+Nagel, logistics, messenger RNA, Moderna, mRNA, pandemic, pharma hub, QuickSTAT, Robert Coyle, Storage, supply chain, therapeutics, vaccines, Warehousing
(PRESS RELEASE) COPENHAGEN, 26-Nov-2020 — /EuropaWire/ — Global biotechnology company Novozymes announces the appointment of Morten Enggaard Rasmussen as Executive Vice President of People, Sustainability & Brand succeeding Thomas Videbæk. Morten will take up his new position on 1 April, … Read the full press release
Posted in Denmark, Management, News, Pharma & Biotech, Science, Technology
Tagged appointment, biotechnology, Ester Baiget, human resources, Morten Enggaard Rasmussen, Novozymes, sustainability, Thomas Videbæk, Vestas
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?